Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,835 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vasovagal reactions after COVID-19 vaccination in Japan.
Okuyama M, Morino S, Tanaka K, Nakamura-Miwa H, Takanashi S, Arai S, Ochiai M, Ishii K, Suzuki M, Oka A, Morio T, Tanaka-Taya K. Okuyama M, et al. Among authors: tanaka k, tanaka taya k. Vaccine. 2022 Sep 29;40(41):5997-6000. doi: 10.1016/j.vaccine.2022.08.056. Epub 2022 Aug 25. Vaccine. 2022. PMID: 36068111 Free PMC article.
Estimating influenza vaccine effectiveness among older adults using an integrated administrative database and the implications of potential bias: A population-based cohort study in Japan.
Kasamatsu A, Yahata Y, Fukushima W, Sakamoto H, Tanaka K, Takigawa M, Izu K, Nishino Y, Suzuki M, Kamiya H. Kasamatsu A, et al. Among authors: tanaka k. Vaccine. 2024 Dec 2;42(26):126488. doi: 10.1016/j.vaccine.2024.126488. Epub 2024 Oct 31. Vaccine. 2024. PMID: 39486352
Ethiodized Oil Pickering Emulsion for Sustained Release of Anti-PD-L1 Antibodies.
Satomura H, Kimura Y, Kennoki N, Tomotake K, Yano H, Koretsune Y, Katayama D, Tanaka K, Ono Y, Higashihara H, Tomiyama N. Satomura H, et al. Among authors: tanaka k. J Vasc Interv Radiol. 2025 Jan 23:S1051-0443(25)00134-4. doi: 10.1016/j.jvir.2025.01.040. Online ahead of print. J Vasc Interv Radiol. 2025. PMID: 39863284
Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease.
Yoshimura Y, Yamanouchi M, Koizumi R, Mizuno H, Oba Y, Kurihara S, Suwabe T, Tsunoda S, Kishioka A, Takeuchi T, Tanimizu H, Kamido H, Yoshimoto M, Sugimoto H, Ikuma D, Tanaka K, Inoue N, Sekine A, Hasegawa E, Wada T, Ubara Y, Sawa N. Yoshimura Y, et al. Among authors: tanaka k. Rheumatology (Oxford). 2025 Jan 25:keaf050. doi: 10.1093/rheumatology/keaf050. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 39862405
Apoptosis in Cancer Biology and Therapy.
Moyer A, Tanaka K, Cheng EH. Moyer A, et al. Among authors: tanaka k. Annu Rev Pathol. 2025 Jan;20(1):303-328. doi: 10.1146/annurev-pathmechdis-051222-115023. Annu Rev Pathol. 2025. PMID: 39854189 Review.
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX.
Stoop TF, Sugawara T, Oba A, Feld IM, van Roessel S, van Veldhuisen E, Wu YHA, Nishino J, Ali M, Alseidi A, Sauvanet A, Mirabella A, Sa Cunha A, Kokkola A, Groot Koerkamp B, Pietrasz D, Kleive D, Butturini G, Malleo G, van Laarhoven HWM, Frigerio I, Dembinski J, He J, Gagnière J, Kleeff J, Ramia JM, Roberts KJ, Labori KJ, Marino MV, Falconi M, B Mortensen M, Lesurtel M, Bonds M, Chatzizacharias N, Strobel O, Turrini O, Griffin O, Franklin O, Pfeiffer P, Schulick RD, Salvia R, de Wilde RF, Dokmak S, Rodriguez Franco S, Augustinus S, Burgdorf SK, Crippa S, Hackert T, Tarvainen T, Burns WR, Messersmith W, Wilmink JW, Burkhart RA, Del Chiaro M, Besselink MG; Scientific Committee of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA) and International Collaboration on Advanced Pancreatic Cancer. Stoop TF, et al. JAMA Oncol. 2025 Jan 23. doi: 10.1001/jamaoncol.2024.5917. Online ahead of print. JAMA Oncol. 2025. PMID: 39847363
Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group.
Yasuda K, Kiyota N, Matsuura K, Saito S, Honma Y, Imamura Y, Tanaka K, Zenda S, Onoe T, Kodaira T, Kobayashi S, Aoyama H, Hanai N, Homma A. Yasuda K, et al. Among authors: tanaka k. Front Oncol. 2025 Jan 8;14:1441056. doi: 10.3389/fonc.2024.1441056. eCollection 2024. Front Oncol. 2025. PMID: 39845314 Free PMC article.
Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab-Treated HCC.
Matono T, Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tanaka K, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Ohama H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai M, Kosaka H, Naganuma A, Aoki T, Kuroda H, Yata Y, Nakamura Y, Yoshida O, Nakamura S, Enomoto H, Kaibori M, Hiasa Y, Kudo M; Real‐life Practice Experts for HCC (RELPEC) Study Group; Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group. Matono T, et al. Among authors: tanaka k. J Gastroenterol Hepatol. 2025 Jan 22. doi: 10.1111/jgh.16884. Online ahead of print. J Gastroenterol Hepatol. 2025. PMID: 39844393
18,835 results
You have reached the last available page of results. Please see the User Guide for more information.